Market Cap ₹27 Cr.
Stock P/E
P/B 3.1
Current Price ₹31.3
Book Value ₹ 10
Face Value 10
52W High ₹60
Dividend Yield 0%
52W Low ₹ 24.5
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|
Net Sales | 51 | 45 | 49 | 62 | |
Other Income | 0 | 0 | 0 | 1 | |
Total Income | 51 | 45 | 49 | 63 | |
Total Expenditure | 46 | 41 | 44 | 58 | |
Operating Profit | 5 | 4 | 4 | 5 | |
Interest | 3 | 3 | 3 | 2 | |
Depreciation | 0 | 0 | 0 | 0 | |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
Profit Before Tax | 2 | 1 | 1 | 3 | |
Provision for Tax | 0 | 0 | 0 | 0 | |
Profit After Tax | 1 | 1 | 1 | 2 | |
Adjustments | -0 | -0 | -0 | 0 | |
Profit After Adjustments | 1 | 1 | 1 | 2 | |
Adjusted Earnings Per Share | 2 | 1.1 | 0.1 | 3.9 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 27% | 7% | 0% | 0% |
Operating Profit CAGR | 25% | 0% | 0% | 0% |
PAT CAGR | 100% | 26% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | NA% | NA% | NA% | NA% |
ROE Average | 37% | 26% | 28% | 28% |
ROCE Average | 21% | 18% | 18% | 18% |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Shareholder's Funds | 3 | 4 | 5 | 8 |
Minority's Interest | -0 | -0 | -0 | -0 |
Borrowings | 7 | 14 | 14 | 12 |
Other Non-Current Liabilities | -0 | -0 | -0 | -0 |
Total Current Liabilities | 17 | 9 | 8 | 9 |
Total Liabilities | 27 | 27 | 27 | 28 |
Fixed Assets | 1 | 1 | 0 | 0 |
Other Non-Current Assets | 12 | 12 | 12 | 10 |
Total Current Assets | 14 | 15 | 15 | 17 |
Total Assets | 27 | 27 | 27 | 28 |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Opening Cash & Cash Equivalents | 1 | 1 | 2 | 2 |
Cash Flow from Operating Activities | 1 | 4 | 5 | 4 |
Cash Flow from Investing Activities | -10 | -1 | -0 | 0 |
Cash Flow from Financing Activities | 9 | -3 | -4 | -3 |
Net Cash Inflow / Outflow | 1 | 1 | 0 | 1 |
Closing Cash & Cash Equivalent | 1 | 2 | 2 | 3 |
# | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Earnings Per Share (Rs) | 1.98 | 1.1 | 0.09 | 3.9 |
CEPS(Rs) | 2.74 | 1.61 | 0.11 | 4.13 |
DPS(Rs) | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 5.71 | 6.81 | 0.43 | 12.55 |
Core EBITDA Margin(%) | 8.97 | 8.86 | 8.89 | 7.4 |
EBIT Margin(%) | 8.22 | 8.33 | 8.66 | 8.11 |
Pre Tax Margin(%) | 3.19 | 2.1 | 2.98 | 4.26 |
PAT Margin (%) | 2.37 | 1.5 | 2.25 | 3.76 |
Cash Profit Margin (%) | 3.25 | 2.17 | 2.68 | 3.99 |
ROA(%) | 4.46 | 2.46 | 4.05 | 8.54 |
ROE(%) | 35.01 | 17.76 | 23.72 | 36.8 |
ROCE(%) | 17.83 | 15.81 | 18.16 | 21.47 |
Receivable days | 33.39 | 37.32 | 32.89 | 26.12 |
Inventory Days | 0 | 0 | 0.17 | 0.07 |
Payable days | 3846.28 | 0 | 0 | 4231.49 |
PER(x) | 0 | 0 | 0 | 0 |
Price/Book(x) | 0 | 0 | 0 | 0 |
Dividend Yield(%) | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.36 | 0.39 | 0.32 | 0.24 |
EV/Core EBITDA(x) | 4.01 | 4.33 | 3.51 | 2.88 |
Net Sales Growth(%) | 0 | -11.99 | 9.5 | 27.45 |
EBIT Growth(%) | 0 | -10.8 | 13.82 | 19.44 |
PAT Growth(%) | 0 | -44.38 | 64.7 | 112.82 |
EPS Growth(%) | 0 | -44.45 | -91.67 | 4168.81 |
Debt/Equity(x) | 5.81 | 4.78 | 3.42 | 2.2 |
Current Ratio(x) | 0.82 | 1.57 | 1.8 | 2 |
Quick Ratio(x) | 0.82 | 1.57 | 1.8 | 2 |
Interest Cover(x) | 1.63 | 1.34 | 1.52 | 2.11 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
# | Sep 2023 | Mar 2024 |
---|---|---|
Promoter | 89.51 | 62.64 |
FII | 0 | 0 |
DII | 0 | 0 |
Public | 10.49 | 37.36 |
Others | 0 | 0 |
Total | 100 | 100 |
# | Sep 2023 | Mar 2024 |
---|---|---|
Promoter | 0.54 | 0.54 |
FII | 0 | 0 |
DII | 0 | 0 |
Public | 0.06 | 0.32 |
Others | 0 | 0 |
Total | 0.6 | 0.86 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About